[1]
“The prevalence and risk factors for dyslipidaemia in human immunodeficiency virus-infected children on highly active antiretroviral therapy in Kano, Nigeria”, Ann Afr Med Res, vol. 3, no. 1, Sep. 2020, doi: 10.4081/aamr.2020.103.